These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 17726019)

  • 41. Calcium-regulated interaction of Sgt1 with S100A6 (calcyclin) and other S100 proteins.
    Nowotny M; Spiechowicz M; Jastrzebska B; Filipek A; Kitagawa K; Kuznicki J
    J Biol Chem; 2003 Jul; 278(29):26923-8. PubMed ID: 12746458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The receptor for advanced glycation end products influences the expression of its S100 protein ligands in melanoma tumors.
    Meghnani V; Wagh A; Indurthi VS; Koladia M; Vetter SW; Law B; Leclerc E
    Int J Biochem Cell Biol; 2014 Dec; 57():54-62. PubMed ID: 25310905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell cycle related signaling in Neuro2a cells proceeds via the receptor for advanced glycation end products.
    Schmidt A; Kuhla B; Bigl K; Münch G; Arendt T
    J Neural Transm (Vienna); 2007; 114(11):1413-24. PubMed ID: 17564756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measuring binding of S100 proteins to RAGE by surface plasmon resonance.
    Leclerc E
    Methods Mol Biol; 2013; 963():201-13. PubMed ID: 23296613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes.
    Figarola JL; Shanmugam N; Natarajan R; Rahbar S
    Diabetes; 2007 Mar; 56(3):647-55. PubMed ID: 17327432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Demonstration of heterodimer formation between S100B and S100A6 in the yeast two-hybrid system and human melanoma.
    Yang Q; O'Hanlon D; Heizmann CW; Marks A
    Exp Cell Res; 1999 Feb; 246(2):501-9. PubMed ID: 9925766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches.
    Xie J; Burz DS; He W; Bronstein IB; Lednev I; Shekhtman A
    J Biol Chem; 2007 Feb; 282(6):4218-31. PubMed ID: 17158877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family.
    Filipek A; Jastrzebska B; Nowotny M; Kuznicki J
    J Biol Chem; 2002 Aug; 277(32):28848-52. PubMed ID: 12042313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human muscle satellite cells show age-related differential expression of S100B protein and RAGE.
    Beccafico S; Riuzzi F; Puglielli C; Mancinelli R; Fulle S; Sorci G; Donato R
    Age (Dordr); 2011 Dec; 33(4):523-41. PubMed ID: 21140295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2.
    Shaw SS; Schmidt AM; Banes AK; Wang X; Stern DM; Marrero MB
    Diabetes; 2003 Sep; 52(9):2381-8. PubMed ID: 12941779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays.
    Hsieh HL; Schäfer BW; Sasaki N; Heizmann CW
    Biochem Biophys Res Commun; 2003 Jul; 307(2):375-81. PubMed ID: 12859967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products.
    Shanmugam N; Reddy MA; Natarajan R
    J Biol Chem; 2008 Dec; 283(52):36221-33. PubMed ID: 18854308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neural-activity-dependent release of S100B from astrocytes enhances kainate-induced gamma oscillations in vivo.
    Sakatani S; Seto-Ohshima A; Shinohara Y; Yamamoto Y; Yamamoto H; Itohara S; Hirase H
    J Neurosci; 2008 Oct; 28(43):10928-36. PubMed ID: 18945900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.
    Huttunen HJ; Fages C; Rauvala H
    J Biol Chem; 1999 Jul; 274(28):19919-24. PubMed ID: 10391939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. S100 to receptor for advanced glycation end-products binding assay: looking for inhibitors.
    Padilla L; Dakhel S; Hernández JL
    Biochem Biophys Res Commun; 2014 Mar; 446(1):404-9. PubMed ID: 24613850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
    Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of RAGE signaling through the intracellular delivery of inhibitor peptides by PEI cationization.
    Putranto EW; Murata H; Yamamoto K; Kataoka K; Yamada H; Futami J; Sakaguchi M; Huh NH
    Int J Mol Med; 2013 Oct; 32(4):938-44. PubMed ID: 23934084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. S100B's double life: intracellular regulator and extracellular signal.
    Donato R; Sorci G; Riuzzi F; Arcuri C; Bianchi R; Brozzi F; Tubaro C; Giambanco I
    Biochim Biophys Acta; 2009 Jun; 1793(6):1008-22. PubMed ID: 19110011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of advanced glycation end products in cellular signaling.
    Ott C; Jacobs K; Haucke E; Navarrete Santos A; Grune T; Simm A
    Redox Biol; 2014; 2():411-29. PubMed ID: 24624331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation.
    Huang YK; Chou RH; Yu C
    J Biol Chem; 2016 Jul; 291(27):14300-14310. PubMed ID: 27226584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.